The FDA-approved Anti-Cancer Drugs, Streptozotocin and Floxuridine, Reduce the Virulence of Staphylococcus Aureus

Scientific Reports - United Kingdom
doi 10.1038/s41598-018-20617-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Clinically Approved Drugs Inhibit the Staphylococcus Aureus Multidrug NorA Efflux Pump and Reduce Biofilm Formation

Frontiers in Microbiology
Microbiology
2019English

Repurposing FDA-approved Drugs for Anti-Aging Therapies

Biogerontology
AgingGerontologyGeriatrics
2016English

Analysis of FDA Approved Anticancer Drugs Reveals the Future of Cancer Therapy

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2004English

A Review on the Drugs Approved by US-FDA and DCGI

TEXILA INTERNATIONAL JOURNAL OF CLINICAL RESEARCH
2016English

Quantitative Analysis on the Characteristics of Targets With FDA Approved Drugs

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2008English

FDA Approved Drugs With Broad Anti-Coronaviral Activity Inhibit SARS-CoV-2 in Vitro

2020English

Possible FDA-approved Drugs to Treat Ebola Virus Infection

Infectious Diseases of Poverty
MedicineEnvironmentalPublic HealthInfectious DiseasesOccupational Health
2015English

The Staphylococcus-Specific Gene RSR Represses Agr and Virulence in Staphylococcus Aureus

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2010English

Identification of FDA-approved Drugs That Computationally Bind to MDM2

Chemical Biology and Drug Design
BiochemistryOrganic ChemistryDrug DiscoveryMolecular MedicinePharmacology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy